Board of Directors

 

William Smith_Cropped

William B. Smith, MD, FACC

President

Professor of Medicine, University of Tennessee Medical Center.  President, New Orleans Center for Clinical Research and Volunteer Research Group.William B. Smith, MD, FACC, is currently a Professor of Medicine at the University of Tennessee Medical Center in Knoxville, Tennessee.  He is board certified in Nephrology, Internal Medicine and Cardiology with prior board certification in Critical Care Medicine. Dr. Smith is the President of New Orleans Center for Clinical Research and Volunteer Research Group located within the University of Tennessee Medical Center.  Dr. Smith has been involved as a Principal Investigator in over 1800 clinical research studies to include first-in-man, cardiac disease, renal/hepatic disease,  healthy volunteers, diabetes, numerous vaccines, women’s health, HSDD,  obesity, Parkinson’s, Alzheimer’s, Multiple Sclerosis,  and smoking cessation.

Charles

Charles H. Pierce, MD, PhD, FCP, CPI

President Elect

Charles is an APPI/APCR/ACRP Certified Principal Investigator. He is actively involved in Webinars and workshops giving the clinical investigator and staff an understanding and appreciation of the ethics as well as the science and regulations governing clinical research with drugs or devices. Charles’ active management experience in the medical research industry gives him first-hand practical experience and knowledge to develop Phase I, IIa confined study Clinical Pharmacology Units (CPU’s). From experience and practical know-how, the special needs of these units (from the floor plans to operational SOPs) has been of added value to those considering this venture. Charles is a Fellow and Life Member of the American Academy of Family Physicians and Emeritus fellow of the American College of Clinical Pharmacology (ACCP) of which he was a Regent 1995-2000, Chairman of the 2001 annual meeting, and the 2004 recipient of the Nathaniel Kwitt Distinguished Service Award. He chaired the 2010 successful ACPU Annual Meeting & was a former Trustee from 2007 to 2011. He is also a member of the Academy of Physicians in Clinical Research (APCR) and the 2012 Chair of the Board to trustees of the Academy of the Association of Clinical Research Professionals (ACRP).

Presently, he works part time in Urgent Care, is the Medical Director of the Deaconess Heath Care Van and a 4 year ‘waived’ physician in the Addiction epidemic.

Cheri Enders Klein, PhD, RF

Secretary

Cheri is the Executive Scientific Director of the AbbVie Clinical Pharmacology Research Unit in Grayslake IL. Cheri received her BA in Biology from the University of Chicago and her PhD in Pharmacy (Pharmacokinetics) from the University of Illinois, School of Pharmacy. Dr. Klein joined Abbott/AbbVie in 2002 in Clinical Pharmacokinetics and Pharmacodynamics and was inducted into the Volwiler Society in 2007 as an Associate Research Fellow and in 2017 as a Research Fellow. In 2019 she was named Executive Scientific Director for the AbbVie Clinical Pharmacology Research Unit for both the medical and operations departments.  Dr. Klein has published over 30 peer-reviewed manuscripts and over 60 abstracts (poster and podium presentation) in international scientific meetings primarily in the field of clinical pharmacology. Dr. Klein was an adjunct Associate Professor at the College of Pharmacy, University of Illinois, served as a Scientific Committee member for the International Workshop of the Clinical Pharmacology of HIV Therapy, served on the Abbott ECG and Arrhythmia committee and participated in the PhRMA LD-KIT for renal impairment studies. She has been a key contributor to several NDA/MA approvals and is an expert in biopharmaceutics issues related to insoluble compounds, clinical drug interactions and PKPD modeling for both efficacy and safety measures.​

parizek_angie (3)

Angie Parizek

Treasurer

Angie Parizek is the global Vice President of Early Patient Solutions for PRA Early Development Services where she manages a global team in the oversight and management of PRA’s early phase (Ph I -2a) clinical trials. Angie has been with 9 years taking and has been conducting early phase research for >20 years with progressive responsibilities.  Prior to PRA, Angie worked for MDS (now Celerion) and ICON.  Angie is a Certified Lean Six Sigma Green Belt and has a Bachelor’s degree in Biology. She is a member of ACRP and ACPU and hosted the 2003 ACPU Annual Meeting. She is based in Lenexa Kansas.

Angela_cropped

Angela Baker 

Immediate Past President

Angela is Executive Director of Strategic Alliances for PRA Early Development Services where she has worked for 9 years. She previously worked in many different early phase capacities including clinical operations, recruitment & screening, marketing, budgets and contracts and business development. Angela was a former trustee for ACPU and worked on the program committee for several annual meetings including chairing the 2012 Annual Meeting hosted by the Hosted by the National Institutes of Health (NIH) Clinical Center. She also served on the Drug Information Association (DIA) Phase I Special Interest Area Committee (SIAC) as a charter member. Angela earned her Master’s in Healthcare Administration (MHA) from the University of Southern Indiana and resides in Newburgh, IN

Denese Haak

Denese Haak

Trustee

Denese is the Senior Director, CRU Site Head at the ICON Clinical Research Unit in San Antonio, Texas. She has 17 years clinical research experience managing and oversighting both early and late phase projects across many therapeutic areas.  Denese began her research career in 2003 as a Study Coordinator and has operated in the roles of Study Manager, Manager of Study Management, Associate Director of Operations, Director of Operations and Site Director.  Fun fact:  Denese lives for the beach and spends most every summer weekend in Port Aransas, Texas.
Luana P headshot

Luana Pesco Koplowitz, MD, PhD, FCP, FFPM

Trustee

Luana is the President and Chief Medical & Scientific Officer of DUCK FLATS PharmaLuana is a pediatric and adult clinical pharmacologist with over 30 years’ experience in global R & D from pre-IND to NDA for both pharmaceutical and biotechnology compounds. She is a member of the Advisory Committee of the FDA/Pharma-sponsored Cardiac Safety Research Consortium (CSRC), member of the FDA/EMA/C-Path Pediatric Committee (International Neonatal Consortium).Luana has specific focus on translational medicine, with emphasis on both nonclinical and clinical data and extensive responsibilities on over 30 approved NDAs, 15 sNDAs and over 200 INDs in multiple therapeutic areas across large, medium and small pharmaceutical/biotechnology companies.
Kerri Weigand headshot

 Kerri Weingard

Trustee

Kerri is a founding partner and global chief operating officer at Verified Clinical Trials (VCT).  VCT is the largest global research subject database to reduce dual enrollment and prevent protocol violations. Ms. Weingard is also the CEO and founder of Study Scavenger and Clinical Hero. Both companies are dedicated to research subject recruitment and education. Ms. Weingard, who is a nurse practitioner, holds a master’s degree in science from Stony Brook University. She, before creating VCT and Study Scavenger, has conducted over 500 clinical trials as a research administrator and sub-investigator. She has more than two decades of experience in the field and is a member of a number of professional organizations, including the American Society for Clinical Pharmacology and Therapeutics, the Drug Information Association and the Association of Clinical Research Professionals.
Gary

David J. Wyatt, MD

Trustee

David is Vice President Medical Affairs at Syneos Health Clinical Solutions (Previously INC Research/inVentiv Health). David was previously in primary care medicine for 14 years, currently practicing full-time in Early Phase Pharmaceutical Clinical Trials. David also serves as Principal Investigator providing medical and protocol safety oversight and organizational responsibility for the safety team and Sub-Investigator(s) at Syenos Phase I clinic in Miami, FL.
David

Gary Zammit, PhD

Trustee

Gary Zammit, PhD, is the President & CEO of Clinilabs, a full-service CRO that provides clinical drug development to industry, focusing on CNS therapeutics.  He also is an Associate Clinical Professor of Psychiatry, Icahn School of Medicine at Mount Sinai (New York, NY).  Dr. Zammit earned a Ph.D. degree in clinical psychology, with a focus in neurophysiology, from the University of Toledo (Toledo, OH), where he won both the Turin Service Award and the Leckie Scholar Award.  Dr. Zammit completed an internship and clinical research fellowship in the Department of Psychiatry at the New York Hospital – Cornell University Medical College (White Plains, NY), where he won the Alumni Award for Excellence.  Dr. Zammit has authored two books and over 200 articles and abstracts that have appeared in medical journals.